🇺🇸 FDA
Pipeline program

Parathyroid Hormone (PTH)

FP-001-IM

Phase 3 small_molecule completed

Quick answer

Parathyroid Hormone (PTH) for Osteoporosis is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Osteoporosis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials